Annabelle Walz
Basel, BS 4001, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Using Next Generation Chemiluminescent Probes to Improve the Plasmodium falciparum in vitro Parasite Reduction Ratio (PRR) Assay.
Journal: ACS infectious diseases
Published: January 23, 2026
Next Generation Chemiluminescent Probes for Antimalarial Drug Discovery.
Journal: ACS infectious diseases
Published: April 01, 2024
Incomplete Plasmodium falciparum growth inhibition following piperaquine treatment translates into increased parasite viability in the in vitro parasite reduction ratio assay.
Journal: Frontiers in cellular and infection microbiology
Published: March 06, 2024
In vivo antimalarial efficacy of Artemisia afra powder suspensions.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: January 04, 2024
The Parasite Reduction Ratio (PRR) Assay Version 2: Standardized Assessment of Plasmodium falciparum Viability after Antimalarial Treatment In Vitro.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 20, 2022
New In Vitro Interaction-Parasite Reduction Ratio Assay for Early Derisk in Clinical Development of Antimalarial Combinations.
Journal: Antimicrobial agents and chemotherapy
Published: October 05, 2022
Parasite Viability as a Measure of In Vivo Drug Activity in Preclinical and Early Clinical Antimalarial Drug Assessment.
Journal: Antimicrobial agents and chemotherapy
Published: June 21, 2022
Stochastic Protein Alkylation by Antimalarial Peroxides.
Journal: ACS infectious diseases
Published: October 19, 2019
Anti-malarial ozonides OZ439 and OZ609 tested at clinically relevant compound exposure parameters in a novel ring-stage survival assay.
Journal: Malaria journal
Published: September 17, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026